Modifications of biochemical markers of bone and collagen turnover during corticosteroid therapy

被引:17
作者
Conti, A
Sartorio, A
Ferrero, S
Ferrario, S
Ambrosi, B
机构
[1] UNIV MILAN,IST SCI ENDOCRINE,MILAN,ITALY
[2] OSPED CADUTI BOLLATESI,DIV GEN MED,BOLLATE,ITALY
关键词
autoimmune disorders; bone Gla protein; collagen; steroids treatment; telopeptide;
D O I
10.1007/BF03349848
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Serum bone Gla protein (BGP), carboxyterminal cross-linked telopeptide of type I collagen (ICTP) and aminoterminal propeptide of type III procollagen (PIIINP) levels were determined in 8 patients with autoimmune disorders (2 with systemic lupus erythematosus, 3 with rheumatoid arthritis, 2 with Sjogren's syndrome and 1 with mixed connective tissue disease) before and after 1, 2 and 4 months of treatment with oral prednisone (at a dosage of 1 mg/kg bw/day, p.o. during the first month, then reduced to 0.1-0.2 mg/kg bw/day), Before treatment, mean serum BGP (mean+/-SE: 5.3+/-0.4 ng/ml) and ICTP (2.8+/-0.2 ng/ml) levels were similar to those recorded in an age and sex matched control group (n=40: 5.4+/-0.1 ng/ml and 4.1+/-0.3 ng/ml, respectively), On the other hand, serum PIIINP levels (2.2+/-0.3 ng/ml) were significantly (p<0.008) lower than those found in controls (3.3+/-0.2 ng/ml). During glucocorticoid therapy, serum BGP levels significantly decreased after 1 month (2.9+/-0.4 ng/ml; p<0.001), but returned to baseline values after 2 and 4 months of treatment (4.7+/-0.4 ng/ml and 5.3+/-0.3 ng/ml, respectively), On the contrary, no significant changes were observed in serum ICTP levels during treatment (1st month: 2.7+/-0.4 ng/ml; 2nd month: 3.0+/-0.4 ng/ml; 4th month: 2.4+/-0.3 ng/ml), Serum PIIINP mean concentration significantly decreased after 1 (1.6+/-0.3 ng/ml; p<0.004) and 2 months of glucocorticoid administration (1.5+/-0.2 ng/ml; p<0.01); after 4 months, serum PIIINP levels were again reduced as before therapy (1.8+/-0.2 ng/ml). In conclusion, our study shows the presence of normal bone turnover indexes and of altered collagen synthesis in patients with autoimmune disorders, The use of high doses of oral steroids is associated with a prompt decrease of bone formation and collagen synthesis, without any significant changes in bone resorption; however, the negative effects on bone formation and collagen synthesis seem to revert after lowering corticosteroid dosage, Serial determinations of the markers of bone and collagen turnover are able to give useful and reliable information on the peripheral effects of steroids excess.
引用
收藏
页码:127 / 130
页数:4
相关论文
共 26 条
[1]   BONE TURNOVER DURING HIGH-DOSE INHALED CORTICOSTEROID TREATMENT [J].
ALI, NJ ;
CAPEWELL, S ;
WARD, MJ .
THORAX, 1991, 46 (03) :160-164
[2]  
ALS OS, 1986, ACTA MED SCAND, V219, P209
[3]  
CUTRONEO KR, 1981, COLLAGEN REL RES, V1, P557
[4]  
DELMAS PD, 1993, PRESSE MED, V22, P263
[5]   MEAN WALL THICKNESS AND FORMATION PERIODS OF TRABECULAR BONE PACKETS IN CORTICOSTEROID-INDUCED OSTEOPOROSIS [J].
DEMPSTER, DW ;
ARLOT, MA ;
MEUNIER, PJ .
CALCIFIED TISSUE INTERNATIONAL, 1983, 35 (4-5) :410-417
[6]   SERUM AND URINARY MARKERS OF BONE REMODELING - ASSESSMENT OF BONE TURNOVER [J].
EPSTEIN, S .
ENDOCRINE REVIEWS, 1988, 9 (04) :437-449
[7]  
ERIKSEN EF, 1993, J BONE MINER RES, V8, P127
[8]   EFFECTS OF PREDNISONE AND DEFLAZACORT ON MINERAL METABOLISM AND PARATHYROID-HORMONE ACTIVITY IN HUMANS [J].
GENNARI, C ;
IMBIMBO, B ;
MONTAGNANI, M ;
BERNINI, M ;
NARDI, P ;
AVIOLI, LV .
CALCIFIED TISSUE INTERNATIONAL, 1984, 36 (03) :245-252
[9]  
GEVERS G, 1989, BR J RHEUMATOL, V28, P207
[10]   BONE STUDIES IN PATIENTS ON PROLONGED SYSTEMIC CORTICOSTEROID-THERAPY FOR ASTHMA [J].
GREENBERGER, PA ;
HENDRIX, RW ;
PATTERSON, R ;
CHMIEL, JS .
CLINICAL ALLERGY, 1982, 12 (04) :363-368